课题基金 / 基金详情

Analysis of newly recognized amplified region in 1q21p in hepatocellular carcinoma

Analysis of newly recognized amplified region in 1q21p in hepatocellular carcinoma
肝细胞癌1q21p新识别扩增区域分析
批准号:
20590790
负责人:
ITOH Yoshito
金额:
$2.91万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2010

项目摘要

项目成果

ITOH Yoshito的其他基金

相似基金

相关文献

中文摘要
翻译
我们认为,肝癌细胞基因组的变化与肝癌细胞的生长或恶变密切相关。我们已经报道了位于CREB/ATF家族1q21p的CREB3L4(cAMP反应元件结合蛋白3样蛋白)在肝癌组织中高水平表达。在进一步的研究过程中,我们发现转录辅助因子P300的核表达与人肝癌的血管侵袭和肝内转移密切相关。此外,我们还发现P300在肝细胞癌中的高表达与上皮间充质转化样表型改变和细胞周期蛋白D1/β-连环蛋白依赖性生长有关,这可能是导致患者预后不良的原因之一。
英文摘要
We believed that the changes in the genomes derived from HCC were deeply involved in the growth or malignant transformation of HCC cells. We have already reported that CREB3L4(cyclic AMP responsive element binding protein 3-like 4) located in 1q21p, which belonged to the CREB/ATF family, was amplified and was expressed in high levels in HCC samples. In the process of further research, we found that the nuclear expression of P300, a transcriptional co-factor, was associated with the vascular invasion and intrahepatic metastasis of human HCCs. Furthermore, we identified that high expression of P300 in HCC was associated with epithelial mesenchymal transition-like phenotypic change and cyclin D1/beta-catenin dependent growth of HCC cells which might explain the poor prognosis of the patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ERK5 is a target for gene amplification at 17q11 and promotes cell growth in hepatocellular carcinoma by regulating mitotic entry
ERK5 是 17q11 基因扩增的靶标,通过调节有丝分裂进入促进肝细胞癌的细胞生长
DOI: --
发表时间: 2009
期刊: Genes Chromosomes Cancer 48
影响因子: --
作者: [Zen K, et al.]
通讯作者: et al.
DOI: --
发表时间: 2009-12
期刊: Anticancer research
影响因子: 2
作者: [Mio Endo;K. Yasui;T. Nakajima;Y. Gen;Kazuhiro Tsuji;O. Dohi;Keika Zen;H. Mitsuyoshi;M. Minami;Y. Itoh;M. Taniwaki;Shinji Tanaka;S. Arii;T. Okanoue;T. Yoshikawa]
通讯作者: Mio Endo;K. Yasui;T. Nakajima;Y. Gen;Kazuhiro Tsuji;O. Dohi;Keika Zen;H. Mitsuyoshi;M. Minami;Y. Itoh;M. Taniwaki;Shinji Tanaka;S. Arii;T. Okanoue;T. Yoshikawa
細胞癌におけるtranscriptional cofactor P300の発現とその臨床的意義
转录辅助因子P300在细胞癌中的表达及其临床意义
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: [横溝千尋, 山口寛二, 新美敏久, 西村健, 藤井秀樹, 吉川敏一, 伊藤義人]
通讯作者: 伊藤義人
High expression of P300 in HCC is associated with EMT-like phenotypic change and cyclin D1/beta-catenin dependent growth of HCC cells which may underlie poor prognosis of the patients
HCC 中 P300 的高表达与 HCC 细胞的 EMT 样表型变化和细胞周期蛋白 D1/β-连环蛋白依赖性生长相关,这可能是患者预后不良的原因
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: [Yokomizo C, Yamaguchi K, Nishimura T, N Tochiki, Fujii H, Nakajima T, Umemura A, Okanoue T, Itoh Y]
通讯作者: Itoh Y
6
    The role of Apg-2 in hepatocarcinogenesis and regeneration
    • 批准号:
      24590991
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.41万
    • 财政年份:
      2012
    • 负责人:
      ITOH Yoshito
    • 依托单位:
    Investigation for the mechanisms of metastasis and growth of HCC via chemokine receptors
    • 批准号:
      18590743
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.36万
    • 财政年份:
      2006
    • 负责人:
      ITOH Yoshito
    • 依托单位:
    Lifecycle Analysis of Traffic Infrastructures using Accelerated Exposures Test Results
    • 批准号:
      15360237
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $7.49万
    • 财政年份:
      2003
    • 负责人:
      ITOH Yoshito
    • 依托单位:
    Analysis of chemokine/chemokine system involoved in the growth of human hepatocellular carcinoma
    • 批准号:
      15590674
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.05万
    • 财政年份:
      2003
    • 负责人:
      ITOH Yoshito
    • 依托单位:
    海外基金